Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12610000323022
ACTRN12610000323022
Not yet recruiting
未知

Intrathecal baclofen therapy for management of spasticity: An Australian paediatric multicentre prospective audit.

Princess Margaret Hospital for Children0 sites100 target enrollmentApril 21, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCerebral PalsySpinal Cord InjuryNeurological - Other neurological disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
Cerebral Palsy
Sponsor
Princess Margaret Hospital for Children
Enrollment
100
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Princess Margaret Hospital for Children

Eligibility Criteria

Inclusion Criteria

  • •Enrolment in this paediatric long term outcome audit will be offered to new patients offered ITB therapy.
  • •The decision whom is offered ITB therapy in Western Australia rests with Movement Disorder’s team at Princess Margaret Hospital. This decision is made following a multidisciplinary medical assessment process including a test dose of intrathecal baclofen.
  • •Hospitals providing paediatric ITB programmes in Australia include Princess Margaret Hospital for Children (Perth), Royal Childrens Hospital (Melbourne), Monash Medical Centre (Melbourne), Westmead Childrens Hospital (Sydney), Women \& Childrens Hospital (Adelaide) and the Royal Childrens Hospital (Brisbane).

Exclusion Criteria

  • •There are no specific exclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Phase 4
Intrathecal Baclofen therapy with the implanted pump system for Spastic Palsy (Post-marketing clinical trial extended phase 3 after NDA approval)[Spinal cord Origin] Spinal cord Injury, Multiple sclerosis, Spinocerebellar degeneration, Circulatory disorder of the spinal, Ossification of the posterior longitudinal ligament [Cerebral Origin] Cerebral palsy, Traumatic head injury
JPRN-jRCT1080220031DAIICHI SANKYO COMPANY, LIMITED
Completed
Phase 3
Dutch National ITB Study in Children With Cerebral PalsyCerebral PalsySpasticity
NCT00367068Maastricht University18
Completed
Not Applicable
Intrathecal Baclofen Infusion for Reflex sympathetic Dystrophy related dystoniaReflex sympathetic dystrophy (RSD)Signs and SymptomsPain
ISRCTN43633981eiden University Medical Centre (LUMC) (The Netherlands)45
Completed
Phase 2
Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant SpasticityCerebral Palsy
NCT00221611University Hospital, Ghent80
Completed
Not Applicable
The BIRD study. Intrathecal Baclofen Infusion for Reflex Sympathetic Dystrophy related dystonia.Reflex sympathetic dystrophy (RSD) related dystonia.
NL-OMON27484eiden University Medical Centre, Dept. of Neurology45